氨酸及其类似物:药理学,毒理学和生物监测
Emilia Marchei1, Silvia Graziano1, Simona Pichini1
1National Center on Addiction and Doping, National Institute of Health, Rome, Italy; and.
Therapeutic drug monitoring
|February 2, 2026
概括
非芬太尼的合成阿片类药物如兄弟啡正在出现,带来显著的毒理和公共卫生风险. 加强监测和实验室方法对于监测这些强大的μ-阿片类受体激动剂至关重要.
科学领域:
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
- 法医科学 法医科学 法医科学
背景情况:
- 非芬太尼合成阿片类药物的出现,以兄弟啡为例,标志着非法毒品市场的重大转变.
- 这些新型化合物带来了持续的毒理和公共卫生挑战.
研究的目的:
- 审查药理学,毒理学和分析检测brorphine及其类似物.
- 突出监测和应对这些物质传播的挑战.
主要方法:
- 在PubMed和Scopus数据库中进行系统的文献搜索.
- 包括国际组织早期预警平台的数据.
- 审查现有的分析方法来检测兄弟啡.
主要成果:
- 啡是一种强大的μ-阿片类受体激动剂,具有很高的滥用潜力,抗受体和呼吸抑制作用.
- 自2019年以来,在法医样本中越来越多地检测到氨酸及其类型,通常与其他药物混合.
- 有限的验证分析方法和参考材料存在于兄弟啡类似物,阻碍了全面的监测.
结论:
- 兄弟啡和类似药物的增加表明,人们正在向非芬太尼合成阿片类药物过渡.
- 这些物质带来了重大的分析和毒理学挑战.
- 国际监测,改善实验室能力和公共卫生战略对于减轻它们的影响至关重要.
相关概念视频
Cholinergic Antagonists: Pharmacological Actions
1.7K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.7K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management
813
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
813
Inflammatory Bowel Disease IV: Pharmacological Management
610
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
610
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.3K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.6K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.6K


